Lung Transplantation for the Treatment of Vaping Induced, Irreversible, End Stage Lung Injury

Authors

Hassan Nemeh, Henry Ford HealthFollow
Victor Coba, Henry Ford HealthFollow
Maria Chulkov
Arielle H. Gupta, Henry Ford HealthFollow
Nicholas S. Yeldo, Henry Ford HealthFollow
Themistokles Chamogeorgakis, Henry Ford HealthFollow
Daizo Tanaka, Henry Ford HealthFollow
Lisa Allenspach, Henry Ford HealthFollow
Jane Simanovski, Henry Ford HealthFollow
Christina Shanti

Recommended Citation

Nemeh H, Coba V, Chulkov M, Gupta A, Yeldo N, Chamogeorgakis T, Tanaka D, Allenspach L, Simanovski J, and Shanti C. Lung Transplantation for the Treatment of Vaping Induced, Irreversible, End Stage Lung Injury. Ann Thorac Surg 2020.

Document Type

Article

Publication Date

10-29-2020

Publication Title

The Annals of thoracic surgery

Abstract

Recently, there has been a rise in the incidence of E-cigarettes/Vaping Associated Lung Injury (EVALI) in the United States mostly involving Tetrahydrocannabinol (THC)(1). Present treatment strategies for EVALI are aimed at controlling the inflammatory and infectious etiologies in addition to supportive care(2). While most patients improve with supportive measures(3,4) the long-term pulmonary effects of this illness are still not well defined. In this report, we describe a case of EVALI resulting in progressive, irreversible destruction of the lung parenchyma that was treated with double lung transplantation.

Medical Subject Headings

Adolescent; Electronic Nicotine Delivery Systems; Humans; Lung Injury/diagnosis/etiology/surgery; Lung Transplantation/methods; Male; Radiography; Thoracic; Vaping/adverse effects

PubMed ID

33130115

ePublication

ePub ahead of print

Volume

111

Issue

5

First Page

e353

Last Page

e355